Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by coyote13on Nov 13, 2015 9:41pm
337 Views
Post# 24290998

RE:RE:Is it safe to say no Reverse Splitt or am i simply dreaming.

RE:RE:Is it safe to say no Reverse Splitt or am i simply dreaming.Listened to Q3 call. Best Q  info release call yet.  And we traded up on the day. That might be a first. While its not about the quarterly results, a loss that equates to R+D spend is ok in my books. In other words, if resin sales gross profit  can offset G+A,  I'm happy.

PL stayed out of the muck and was thinking about his message delivery,  answers to the analysts Q's. and setting the stage in the months to come. PL is not perfect and few small cap CEO's are.  But I think he gets it done.

There is a plan that has been crafted and will get done as long as the science works. I also believe we have some savvy board members when it comes to validating the strategy, the business model,  investor acceptance and utimately creating shareholder value. 

As for NASDAQ, this will happen. What the rollback is I am not smart enough to know. Sweetspot seems to be 100  million shares.  But  in terms of what PLI has, we should do better.  The investment bankers are all over us but I believe Thomvest is keeping the IB's honest ( if that is possible) . Thomvest is driving the bus to NASDAQ. Thomvest sees  the  value creation that arises from the multiple expansion from a NASDAQ listing applied to a multipronged business strategy that is unfolding in front of us. If the science works across the various parts of our business, look out. To be a long time shareholder has no doubt been  once in a lifetime opportunity IMHO.

The last few weeks and todays call was a turning point in the future of  PLI. The de-risking continues!

GLTA 

Coyote13
Bullboard Posts